Skip to main content
Adam Riker, MD, General Surgery, New Orleans, LA, Anne Arundel Medical Center

AdamIrwinRikerMDFACS

General Surgery New Orleans, LA

Breast, Melanoma, Surgical Oncology (Other than Breast)

Professor and Chief, Section of Surgical Oncology, Louisiana State University, Department of Surgery School of Medicine, New Orleans, LA

Are you Dr. Riker?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 45 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Adam Riker, MD is a general surgeon in New Orleans, Louisiana. He is currently licensed to practice medicine in Louisiana, Wisconsin, and Florida. He is affiliated with Anne Arundel Medical Center and is a Professor and Chief at Department of Surgery School of Medicine.

Education & Training

  • Loyola University Medical Center
    Loyola University Medical CenterResidency, Surgery, 1994 - 2002
  • National Cancer Institute
    National Cancer InstituteFellowship, Complex General Surgical Oncology, 1996 - 1999
  • University of South Florida College of Medicine
    University of South Florida College of MedicineClass of 1994

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2001 - 2026
  • MD State Medical License
    MD State Medical License 1996 - 2023
  • LA State Medical License
    LA State Medical License 2008 - 2019
  • IL State Medical License
    IL State Medical License 1994 - 2017
  • AL State Medical License
    AL State Medical License Active through 2012
  • WI State Medical License
    WI State Medical License 2002 - 2007
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Immunotherapy Drug Used as 1st-Line Therapy for Merkel Cell Carcinoma Improved Survival
    Immunotherapy Drug Used as 1st-Line Therapy for Merkel Cell Carcinoma Improved SurvivalFebruary 7th, 2019
  • Research Providing Promising New Treatments for Melanoma
    Research Providing Promising New Treatments for MelanomaDecember 7th, 2016
  • Cancer Crusaders Hears from LSU Section Chief
    Cancer Crusaders Hears from LSU Section ChiefNovember 30th, 2016

Professional Memberships

Other Languages

  • Chinese (Mandarin)

Hospital Affiliations